Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Hypogonadism 1Fatigue 1Eunuchism 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Specimen Handling 313Magnetic Resonance Spectroscopy 272pembrolizumab 263Carboplatin 190Cyclophosphamide 177Biopsy 177Cisplatin 165Paclitaxel 137Gemcitabine 137Bevacizumab 122fludarabine 115Nivolumab 114Radiotherapy 111venetoclax 98Oxaliplatin 97Fluorouracil 87Docetaxel 85Dexamethasone 83Capecitabine 83Pemetrexed 76Drug Therapy 76Rituximab 75Leucovorin 71durvalumab 70Radiosurgery 67Doxorubicin 64Blood Specimen Collection 64Standard of Care 63Injections 62atezolizumab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Testosterone × 90 days × Clear all
NCT06075953 2026-05-22

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
400 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Roswell Park Cancer Institute

Phase 4 Recruiting
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT04301765 2026-03-31

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting
230 enrolled

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡